Andreas Kalcker is a German biophysicist based in Switzerland who has been researching Chlorine Dioxide for therapeutic use as an alternative oxygen carrier and antiseptic in blood plasma for more than 13 years, with 3 international patents relating to hypoxia, inflammation, infection and sepsis, and several other patents pending.

Recently, an effectiveness of almost 100% has been demonstrated and reported in the treatment of Coronavirus with a treatment duration of only 4 days without any negative side effects.

His main field of work is the programming of frequency devices with a focus on the coherent field effects of cold plasma and the transfer of electrons for cellular communication in the human body.